Skip to main content
Healthcare

STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds

STAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis finds

Feed excerpt — reported by STAT News

The median net price for 202 newly launched drugs, when adjusted for inflation and manufacturer discounts, rose by 35% last year from 2022

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.